Literature DB >> 35653095

Lymphomatoid papulosis during upadaci-tinib treatment for rheumatoid arthritis.

Shin Iinuma, Kei Hayashi, Atsushi Noguchi, Akemi Ishida-Yamamoto.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35653095      PMCID： PMC9170547          DOI： 10.1684/ejd.2022.4238

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   2.805


× No keyword cloud information.
  5 in total

Review 1.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

Review 2.  Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.

Authors:  S Laube; M Stephens; A G Smith; S J Whittaker; B B Tan
Journal:  Br J Dermatol       Date:  2005-06       Impact factor: 9.302

Review 3.  Lymphomatoid papulosis in a patient treated with adalimumab for juvenile rheumatoid arthritis.

Authors:  Ji-Hye Park; Jun Lee; Jae Hyung Lee; Dong-Youn Lee; Eun-Mi Koh
Journal:  Dermatology       Date:  2012-12-13       Impact factor: 5.366

4.  Lymphomatoid Papulosis Type B in a Patient with Crohn's Disease Treated with TNF-Alpha Inhibitors Infliximab and Adalimumab.

Authors:  Márta Medvecz; Norbert Kiss; Judit Hársing; Enikő Kuroli; Gábor Hegede; Judit Csomor; Sarolta Kárpáti; Márta Marschalkó
Journal:  Acta Dermatovenerol Croat       Date:  2019-09       Impact factor: 1.256

5.  Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.

Authors:  Stanley B Cohen; Ronald F van Vollenhoven; Kevin L Winthrop; Cristiano A F Zerbini; Yoshiya Tanaka; Louis Bessette; Ying Zhang; Nasser Khan; Barbara Hendrickson; Jeffrey V Enejosa; Gerd R Burmester
Journal:  Ann Rheum Dis       Date:  2020-10-28       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.